{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-26-000153","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2026-08-05T20:09:49+00:00","discovered_at":"2026-08-05T20:11:00.233951+00:00","generated_at":"2026-08-05T20:11:52.967204+00:00","sec_items":[],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GoodRx appoints Justin Fengler as CFO, replacing Christopher McGinnis","bullets":["Christopher McGinnis to step down as CFO & Treasurer effective Aug 5, 2026; departure not due to disagreement.","Justin Fengler, current Chief Strategy & Operations Officer, appointed CFO & Treasurer effective Aug 6, 2026.","Fengler receives $600k RSU, $600k PSU, $100k cash, and Tier 1 severance plan designation.","McGinnis expected to receive severance per Tier 1 plan and sign separation agreement with non-disparagement.","Fengler has been with GoodRx since 2016, previously SVP of Corporate Strategy & Business Operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-26-000153","json":"https://secwatch.observer/filing/0001809519-26-000153.json","markdown":"https://secwatch.observer/filing/0001809519-26-000153.md","text":"https://secwatch.observer/filing/0001809519-26-000153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/0001809519-26-000153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/gdrx-20260731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:11:52.967204+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}